Skip to content

Anthology Hip Replacement System - Orthopaedic Data Evolution Panel (ODEP) Surveillance Study

Anthology Hip Replacement System - Orthopaedic Data Evolution Panel (ODEP) Surveillance Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04425603
Enrollment
270
Registered
2020-06-11
Start date
2007-04-30
Completion date
2021-11-08
Last updated
2022-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Avascular Necrosis, Primary Osteoarthritis, Primary Total Hip Replacement (THR), Secondary Osteoarthritis

Keywords

THR, Anthology Hip Replacement

Brief summary

This clinical study will verify the clinical and radiographic performance of the prosthesis when used in human subjects over a period of 10 years. All complications will be documented.

Detailed description

The clinical evaluations will be based on standard, functional and pain parameters Harris Hip Score pre-operatively, and at 6 months, 3, 5, 7.5 and 10 years post-operatively. Postal Oxford questionnaire preoperatively, and yearly thereafter. The objective of this study is to analyse the clinical and radiographic responses and the complication rates for patients undergoing primary total hip arthroplasty using the Anthology Hip Replacement System (Anthology Hip System).

Interventions

DEVICEAnthology Hip Replacement System

Sponsors

Smith & Nephew Orthopaedics AG
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

1. Those presenting with primary or secondary osteoarthritis or avascular necrosis of the femoral head or patients suitable for a primary total hip replacement. This is the patient group that will benefit from operative surgery to treat osteoarthritis. 2. Those deemed capable of giving informed consent, understanding the aims of the study and expressing willingness to comply with the post-operative review programme. Patients capable of giving informed consent are eligible for inclusion into the study. 3. Participants who signed the Ethics Committee approved specific Informed Consent Form prior to surgery. Patients who have not given informed consent will not be eligible for inclusion into the study.

Exclusion criteria

1. Patients whose prospects for a recovery to independent mobility would be compromised by known coexistent, medical problems. 2. Patients not suitable for primary hip replacement. 3. Patients with active or suspected infection.

Design outcomes

Primary

MeasureTime frameDescription
Harris Hip Score - 10 years10 years post operativeThe Harris Hip Score is a joint specific score that consists of 10 items covering domains of pain (1 item, 0-44 points), function (7 items, 0-47 points), functional activities, absence of deformity (1 item, 0 or 4 points), and hip range of motion (2 items, 0-5 points). Scores range from 0 (worst) to 100 (best).
Quality of life with Oxford Hip Score (postal) - 10 years10 years post operativePatients are asked to reflect on their pain and functional ability over the previous four weeks. There are two domains (pain and function) with six items or questions in each. Each item has five possible responses. In the original scoring responses were from 1 = least difficult to 5= most difficult. Item scores are summed to give a total score from anywhere between 12 and 60. The lower the score, the better the outcome.
Quality of life with EuroQol Questionnaire (EQ-5D) -10 years10 years post operativeThe descriptive system consists of five dimensions (mobility, self-care, usual activities, pain/discomfort, anxiety/depression) each of which takes one of three responses. The responses record three levels of severity (no problems/some or moderate problems/extreme problems) within a particular dimension. The EQ VAS records the respondent's self-rated health on a vertical, visual analogue scale where the endpoints are labelled 'Best imaginable health state' and 'Worst imaginable health state'. This information can be used as a quantitative measure of health outcome as judged by the individual respondents.

Secondary

MeasureTime frameDescription
Device-related complications6 months, 3 years, 5 years, 7.5 years, and 10 years post operativeComplications and adverse events will be noted at each follow-up and using clinical judgement it will be determined whether the event is device related
Number of revisions or withdrawals for any reason6 months, 3 years, 5 years, 7.5 years, and 10 years post operative
Harris Hip ScorePre-operative and 6 months, 3 years, 5 years, and 7.5 years post operativeThe Harris Hip Score is a joint specific score that consists of 10 items covering domains of pain (1 item, 0-44 points), function (7 items, 0-47 points), functional activities, absence of deformity (1 item, 0 or 4 points), and hip range of motion (2 items, 0-5 points). Scores range from 0 (worst) to 100 (best).
Survival Rate10 years post operativeThe survival rate will be calculated according to the method in accordance with Kaplan-Meier stating the 95% confidence interval.
Radiographic evaluationsPre-operative, peri-operative, 6 months, 3 years, 5 years, 7.5 years, and 10 years post operativeAnterior-posterior, and lateral view x-rays of the femur and pelvis of the affected hip will be evaluated. X-rays will be reviewed and specific information regarding presence/absence/location of radiolucent lines and implant positions and alignment will be recorded.
Quality of life with Oxford Hip Score (postal)Pre-operative and 6 months, 3 years, 5 years, and 7.5 years post operativePatients are asked to reflect on their pain and functional ability over the previous four weeks. There are two domains (pain and function) with six items or questions in each. Each item has five possible responses. In the original scoring responses were from 1 = least difficult to 5= most difficult. Item scores are summed to give a total score from anywhere between 12 and 60. The lower the score, the better the outcome.
Quality of life with EuroQol Questionnaire (EQ-5D)Pre-operative and 6 months, 3 years, 5 years, and 7.5 years post operativeThe descriptive system consists of five dimensions (mobility, self-care, usual activities, pain/discomfort, anxiety/depression) each of which takes one of three responses. The responses record three levels of severity (no problems/some or moderate problems/extreme problems) within a particular dimension. The EQ VAS records the respondent's self-rated health on a vertical, visual analogue scale where the endpoints are labelled 'Best imaginable health state' and 'Worst imaginable health state'. This information can be used as a quantitative measure of health outcome as judged by the individual respondents.

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026